German Firm Establishes Hub in Côte d’Ivoire

Google+ Pinterest LinkedIn Tumblr +

Leading science and technology company, Merck has opened an office in Abidjan, Côte d’Ivoire.

“This new office will allow us to reinforce and to develop our already existing activities in the country. We will continue to bring specialist and high-quality products to serve patients and help them to improve their quality of life,” said Dr. Karim Bendhaou, President, Merck North and West Africa.

Côte d’Ivoire was picked for its increasing economic, political and social stability.

The German firm’s affiliate office will be the regional hub for its operations in French-speaking countries in Central and West Africa.

Merck also donated two minilabs to detect counterfeits quickly, cost effectively and reliably- in support of Côte d’Ivoire’s fight against counterfeit medicines.

Bendhaou added, “We are pleased that our plan to establish a public-private partnership to combat counterfeits will be translated into effective measures with the donated minilabs, in addition to an awareness campaign led by the Minister of Health and Public Hygiene.”

The company’s fight against counterfeit medicines is part of its health-related corporate responsibility initiatives.

The minilabs will be the first to be used in Côte d’Ivoire. They are manufactured by the Global Pharma Health Fund (GPHF), a charitable initiative financed by Merck.

Côte d’Ivoire ‘s Minister of Health and Public Hygiene, Dr. Raymonde Goudou Coffie thanked Merck for the donation and said the minilabs would reinforce the country’s structures for drug monitoring, reassuring the people of safe medicines.

The oldest pharmaceutical and chemical company in the world, Merck develops innovative technologies, giving access to high-quality health solutions to improve and enhance life.

The office was inaugurated by the Ambassador of the Federal Republic of Germany to Côte d’Ivoire, Dr. Claus Auer and graced by The First Lady of Côte d’Ivoire Dominique Claudine Ouattara.


About Author

Leave A Reply